Alberto Papi is full professor of Respiratory Medicine and Director of the Section of Respiratory Diseases of the Department of Clinical And Experimental Medicine of the University of Ferrara at S.Anna University Hospital, Ferrara, I. Alberto Papi received doctorate in Medicine and Surgery at the University of Ferrara in 1986 (full marks and honours), Board in Respiratory Medicine and Phthisiology at the University of Parma in 1991 (full marks and honours). He has been a Visiting Scientist at the Nebraska Medical Centre, School of Medicine Pulmonary and Critical Care Section (1990) and Clinical Research Fellow at University Medicine of Southampton (U.K.) from 1994 to 1997. Since 1998 he is Honorary Clinical Lecturer at University Medicine of Southampton (U.K.).
The Section of Respiratory Medicine directed by Prof. Papi has a clinical ward of 14 beds, a thoracic endoscopic Unit, Pulmonary lung function laboratories, Day Hospital, Outpatient Clinics, and a Respiratory rehabilitation Unit. About 500 patients are admitted to the clinical ward every year, and we see about 2000 out patients/year, many of which with obstructive lung diseases. The Research Centre on inflammatory and smoking related respiratory diseases (CEMICEF) represents the research core of the Section. It is equipped for the conduction both of clinical trials and of pre-clinical (basic science) research on obstructive lung disorders.
Prof. Papi served as Secretary of the Respiratory Infections Group of the European Respiratory Society.
Since 2014 he is Deputy Director of the Department of Medical SCiences and Deputy Director of the School of Medicine of the University of Ferrara. He is Member of the Asthma Board of the European Academy of Allergy and Clinical Immunology. He his member of the Editorial Board of the American Journal of Respiratory and Critical Care Medicine, the Journal of COPD and peer Reviewer of several prestigious journals.
The principal field of research is airway inflammation in asthma and COPD, its molecular mechanisms and pharmacological modulation. He studied with particular interest the role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms. He coordinated several studies, particularly in asthma and COPD and he has given presentations at national and international meetings. He has published more than 200 original articles in peer reviewed journals and several publications in non-peer reviewed journals.
The Section of Respiratory Medicine directed by Prof. Papi has a clinical ward of 14 beds, a thoracic endoscopic Unit, Pulmonary lung function laboratories, Day Hospital, Outpatient Clinics, and a Respiratory rehabilitation Unit. About 500 patients are admitted to the clinical ward every year, and we see about 2000 out patients/year, many of which with obstructive lung diseases. The Research Centre on inflammatory and smoking related respiratory diseases (CEMICEF) represents the research core of the Section. It is equipped for the conduction both of clinical trials and of pre-clinical (basic science) research on obstructive lung disorders.
Prof. Papi served as Secretary of the Respiratory Infections Group of the European Respiratory Society.
Since 2014 he is Deputy Director of the Department of Medical SCiences and Deputy Director of the School of Medicine of the University of Ferrara. He is Member of the Asthma Board of the European Academy of Allergy and Clinical Immunology. He his member of the Editorial Board of the American Journal of Respiratory and Critical Care Medicine, the Journal of COPD and peer Reviewer of several prestigious journals.
The principal field of research is airway inflammation in asthma and COPD, its molecular mechanisms and pharmacological modulation. He studied with particular interest the role of respiratory viral infections in stable/exacerbated obstructive lung diseases, and the underlying molecular and immunological mechanisms. He coordinated several studies, particularly in asthma and COPD and he has given presentations at national and international meetings. He has published more than 200 original articles in peer reviewed journals and several publications in non-peer reviewed journals.
